使用诺米图来预测患者对高剂量西斯普拉丁的耐受性,在局部区域高级头癌的同时进行化学放射治疗期间
Ming-Yu Lien1,2, Chia-Yu Chen1, Ching-Yun Hsieh1
1Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung City, Taiwan.
Head & neck
|April 16, 2025
概括
这项研究开发了一种名谱,以预测哪些局部晚期头癌患者可以在化疗放射治疗期间耐受高剂量西斯. 该工具使用预治疗因素来指导治疗选择和改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 头部和部癌症 治疗 治疗
- 临床预测模型临床预测模型
背景情况:
- 与高剂量西斯普拉丁同时进行化学放射治疗 (CCRT) 是局部晚期头癌 (LA-HNC) 的标准.
- 患者对高剂量西斯丁不耐受会导致剂量不足或严重的副作用.
- 鉴定能够耐受高剂量西斯丁的患者仍然是一个临床挑战.
研究的目的:
- 开发和验证一个预测名录,用于识别能够耐受高累积思普拉丁剂量 (CCD ≥200 mg/m2) 的患者.
- 帮助选择适合高剂量西斯基CCRT的患者,以优化治疗结果.
主要方法:
- 对1020名接受基于西斯普拉丁的最终CCRT治疗的患者 (2010-2019) 的回顾性审查.
- 使用逐步多变量逻辑回归的预测模型的开发.
- 创建和绩效评估一个nomogram预测CCD完成.
主要成果:
- 多变量分析确定了年龄,瘤部位,第四阶段疾病和血红蛋白水平作为西斯素不耐受性的预测因素.
- 开发的名图表显示出良好的预测准确性 (C指数:0.71,布赖尔分数:0.18).
- 与较低的CCD组相比,较高的CCD组显示出更好的经验状态和中位体质量指数.
结论:
- 经过验证的诺姆图准确地预测了基于预处理特征的CCD≥200 mg/m2的思普拉丁耐受性.
- 这种工具有助于自信地处方高剂量西斯疗法 (每周或每三周一次),以潜在地改善存活率.
- 建议进一步的前性研究为一个全面的nomogram.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
181
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
152
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
152
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
140
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
140